1227170-83-3Relevant academic research and scientific papers
PROCESS FOR PRODUCING FINGOLIMOD SALTS
-
Page/Page column 8, (2012/07/28)
The invention relates to a process for producing pharmaceutically acceptable salts of fingolimod (I), comprising the step of reacting N-[1,1-bis hydroxymethyl-3-(4-octyl phenyl)-propyl]-acylamide (II) with an acidic compound. Furthermore, the invention provides different pharmaceutically acceptable salts of fingolimod and a polymorphic form of fingolimod hydrochloride.
PROCESS FOR PRODUCING FINGOLIMOD SALTS
-
Page/Page column 17, (2011/02/24)
The invention relates to a process for producing pharmaceutically acceptable salts of fingolimod (I), comprising the step of reacting N-[1,1-bis hydroxymethyl-3-(4-octyl phenyl)-propyl]-acylamide (II) with an acidic compound. Furthermore, the invention provides different pharmaceutically acceptable salts of fingolimod and a polymorphic form of fingolimod hydrochloride.
ORGANIC COMPOUNDS
-
Page/Page column 16, (2010/06/15)
The present invention relates to salts, polymorphs and hydrates of 2-Amino-2-[2-(4-C2-20- alky-phenyl)ethyl]propane~1,3~diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.
